Trials / Completed
CompletedNCT03004469
Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia
A Multicentre, Randomized, Double-blind, Parallel-group, Controlled Study, to Assess the Efficacy and Safety of P-3074 Cutaneous Spray, Solution, in the Treatment of Male Pattern Baldness
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 458 (actual)
- Sponsor
- Polichem S.A. · Industry
- Sex
- Male
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to confirm the clinical efficacy and the safety of P-3074 in participants with androgenetic alopecia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | P-3074 | |
| DRUG | Finasteride | |
| DRUG | P-3074 Vehicle | |
| DRUG | Finasteride Placebo |
Timeline
- Start date
- 2016-08-02
- Primary completion
- 2018-03-05
- Completion
- 2018-03-05
- First posted
- 2016-12-28
- Last updated
- 2019-06-20
- Results posted
- 2019-04-19
Locations
46 sites across 5 countries: Belgium, Germany, Hungary, Russia, Spain
Source: ClinicalTrials.gov record NCT03004469. Inclusion in this directory is not an endorsement.